Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
The 95th Annual Meeting of the Japanese Pharmacological Society
Session ID : 95_1-S02-1
Conference information

Symposium
The mechanism of higher-order structure formation and transport function of amino acid transporter super-complexes
*Shushi Nagamori
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

Membrane transport proteins, such as transporters, pumps and channels, cannot fully exert their transport activity simply by being translated as polypeptide chains and inserted into membranes, but demonstrate the physiological transport activity only when the proteins are properly folded and localize to membrane domains where the proteins should function. Heterodimeric Amino acid Transporters (HATs) family consists of a light chain, which has a transport function, and a heavy chain, which is essential for the localization to the plasma membrane. HATs play important roles in various physiological processes. The rBAT (heavy chain)-b0,+AT (light chain) complex, a member of the HAT family, transports cystine and basic and neutral amino acids. Mutations in either b0,+AT or rBAT lead to cystinuria (renal cystine stones). Since the identification of the rBAT and b0,+AT complex in the late '90s, hundreds of pathological mutations have been found. The studies of mutations improved the understanding of the biosynthesis and transport mechanisms of the complex. However, the pathological mechanisms of mutations outside the predicted substrate binding sites remain largely unknown. By combining biochemical analysis and cryo-EM structures, we solved the structure and function of rBAT-b0,+AT and examined their biogenesis. As a result, we found that b0,+AT recognizes the substrates at different amino acid residues depending on the type of substrate. Furthermore, we identified a Ca2+binding site in rBAT, and showed that Ca2+-mediated super-dimerization (dimer x dimer) is a key for the formation of higher-order structures of the complex and its localization to the plasma membrane. Accordingly, we elucidated the pathogenesis of HAT by mutations related to biosynthesis, which is different from mutations in the substrate-binding site. This study provides an understanding of the HAT biogenesis and serves as a guide to develop a new therapeutic approach. At molecular basis, the study lights up a novel role of Ca2+ on membrane protein biogenesis.

Content from these authors
© 2022 The Authors(s)
Previous article Next article
feedback
Top